{"id":"W2792344809","doi":"10.1016/j.clcc.2018.03.001","title":"A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial","year":2018,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Queen's University; Ottawa Hospital; Saskatchewan Cancer Agency; Western University; University of Calgary; Princess Margaret Cancer Centre; BC Cancer Agency; McGill University; University of Ottawa","funders":"Canadian Cancer Society Research Institute; Oncolytics Biotech","keywords":"Medicine; Bevacizumab; Colorectal cancer; Oncology; Internal medicine; Randomized controlled trial; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00426281,0.0005608847,0.002595644,0.0002856047,0.0002481008,0.00004793703,0.0005810554,0.0003137279,0.000750085],"category_scores_gemma":[0.001537515,0.0003587018,0.0003236127,0.0007910819,0.001111269,0.00002415046,0.000162731,0.0005138297,0.000003008046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003581159,"about_ca_system_score_gemma":0.004855343,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05658879,"about_ca_topic_score_gemma":0.8934857,"domain_scores_codex":[0.9924421,0.002873788,0.001836238,0.001170125,0.0007897322,0.0008879905],"domain_scores_gemma":[0.996654,0.0005448513,0.0009194393,0.0005110021,0.000815444,0.0005552573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9284705,0.003511925,0.0528807,0.00002870561,0.001916542,0.00001827088,0.0005954452,0.00003623434,0.001016323,0.000001463586,0.0002158244,0.01130809],"study_design_scores_gemma":[0.7824293,0.2038971,0.003366843,0.0001186636,0.0006339073,0.000001516035,0.0002212552,0.0001461079,0.008351691,0.000009545742,0.0002915416,0.0005324431],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887099,0.0005951573,0.00001234193,0.0001165551,0.000602128,0.00933283,0.0005437807,0.00001837007,0.0000689177],"genre_scores_gemma":[0.9934568,0.0003066974,0.00009699096,0.0002436808,0.0006828986,0.004884966,0.0001101009,0.0001038459,0.0001139903],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.836897,"threshold_uncertainty_score":0.9998865,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07572923921422868,"score_gpt":0.439881470559381,"score_spread":0.3641522313451523,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}